Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)
Ceiling: $225,000
Applications Due:
Closed
Federal
US Department of Health & Human Services (National Institutes of Health)
This grant provides funding to support the development of comprehensive strategies for creating next-generation HIV treatments and prevention methods, helping researchers prepare for FDA approval processes.
Description
The purpose of this Notice of Funding Opportunity (NOFO) is to support the development of a comprehensive and well-defined product development strategy for next-generation treatments for HIV and HIV-associated comorbidities, coinfections and complication and preventive strategies for HIV, as well as facilitating the translation of research findings into drug products that enables submission of an Investigational New Drug (IND) application to the FDA.
Eligibility
States
All
Regions
All
Eligible Entities
State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal organizations, Public housing authorities, Native American tribal organizations, Nonprofits
Funding
Program Funding
Award Ceiling
$225,000
Award Floor
Award Count
Timing
Posted Date
August 14, 2023
App Status
No Longer Accepting Applications
Funder
Funding Source
Source Type
Federal
Contact Name
NIH Grants Information
Contact Email
Contact Phone
--